NCT01659502 Investigator's Initiated Phase II Study for Pancreatic Cancer Patients Status UNKNOWN Phase PHASE2
NCT01657383 Surgical Outcomes Database For Faculty of Hepatopancreatic Biliary Surgery Status COMPLETED Phase N/A
NCT01656044 Negative Pressure Therapy in Preventing Infection After Surgery in Patients With Colon, Rectal, Pancreatic, or Peritoneal Surface Cancer Status COMPLETED Phase NA
NCT01655641 Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery Status UNKNOWN Phase PHASE2/PHASE3
NCT01646697 Slide Interpretation or Standard Surgical Pathology in Assessing Margin Status in Patients With Pancreatic Cancer Undergoing Surgery Status COMPLETED Phase NA
NCT01642875 Early Oral Versus Enteral Nutrition After Pancreatoduodenectomy Status UNKNOWN Phase PHASE4
NCT01641003 Isolation and Characterization of Cancer Stem Cells Using iFP Technique Status UNKNOWN Phase N/A
NCT01640522 Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms Status COMPLETED Phase NA
NCT01632306 A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT01631552 Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01608711 A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002 Status COMPLETED Phase PHASE2
NCT01601808 Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma Status COMPLETED Phase PHASE2
NCT01598584 Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer Status WITHDRAWN Phase PHASE2/PHASE3
NCT01595321 Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the Pancreas Status COMPLETED Phase PHASE2
NCT01589328 Effect of Early Management on PAin and DEpression in Patients With PancreatoBiliary Cancer, EPADE-PB Status COMPLETED Phase NA
NCT01587534 Pancreatic Enzyme Supplementation in Patients With Unresectable Pancreatic Cancer (PESUP) Status COMPLETED Phase PHASE2
NCT01583686 CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer Status TERMINATED Phase PHASE1/PHASE2